Where scientific excellence meets a shared mission to transform patient lives.

Co-Founder & CEO

Dr. Vallejo is a trusted leader in interventional pain management with a special expertise in spinal cord stimulation, clinical trials, and pain science. Ricardo has had formidable results through his career, including the sale of 3 companies to Medtronic.

C-Flow Labs is powered by a highly capable and strategically assembled team of professionals with deep experience across biomedical engineering, product development, clinical research, and commercialization. Together, they bring the technical expertise, operational discipline, and innovative mindset necessary to advance complex medical technologies from concept to market.

The team combines strong academic credentials with practical, hands-on experience in both research and industry environments. Many members hold advanced degrees in engineering, life sciences, and management, and have previously contributed to successful product launches, regulatory submissions, and early-stage startup growth. This mix of academic rigor and real-world execution allows C-Flow Labs to balance scientific excellence with business viability.

Collectively, the team’s skill set spans fluid dynamics, medical device design, computational modeling, manufacturing integration, and regulatory strategy. Their cross-functional collaboration ensures that every stage of development — from prototype design to testing and validation — is guided by both technical precision and commercial awareness.

Beyond the core staff, C-Flow Labs works with a network of consultants and technical specialists who extend the company’s reach in key areas such as intellectual property strategy, clinical testing, and scalable production design. This flexible and cost-efficient structure enables the company to leverage top-tier expertise without compromising agility or fiscal responsibility.

As a unit, the C-Flow Labs team exemplifies innovation backed by disciplined execution — a group of driven professionals capable of translating breakthrough ideas into viable, investor-ready medical technologies positioned for long-term growth and market impact.